This finding provides a better understanding of the differences in PD-1 expression between genders in NSCLC patients and the effect of sex hormones on PD-1 expression and supplies evidence for early lung cancer diagnosis and responsiveness to ICB. The gene discussed is PDCD1; the disease is lung cancer.